vu0364572 and Alzheimer-Disease

vu0364572 has been researched along with Alzheimer-Disease* in 2 studies

Other Studies

2 other study(ies) available for vu0364572 and Alzheimer-Disease

Article	Year
Hippocampal place cell dysfunction and the effects of muscarinic M Hippocampus, 2018, Volume: 28, Issue:8 Topics: Action Potentials; Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Benzamides; Biphenyl Compounds; Disease Models, Animal; Female; Hippocampus; Memory Disorders; Mutation; Neurons; Presenilin-1; Rats; Rats, Inbred F344; Rats, Transgenic; Receptor, Muscarinic M1; Recognition, Psychology	2018
Disease-Modifying Effects of M ACS chemical neuroscience, 2017, 06-21, Volume: 8, Issue:6 Alzheimer's disease (AD) is the leading cause of dementia worldwide, and currently no disease-modifying therapy is available to slow or prevent AD, underscoring the urgent need for neuroprotective therapies. Selective M Topics: Alzheimer Disease; Animals; Benzamides; Biphenyl Compounds; Brain; Maze Learning; Mice; Mice, Transgenic; Neuroprotective Agents; Receptor, Muscarinic M1	2017

Article

Year

Hippocampal place cell dysfunction and the effects of muscarinic M

Hippocampus, 2018, Volume: 28, Issue:8

Topics: Action Potentials; Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Benzamides; Biphenyl Compounds; Disease Models, Animal; Female; Hippocampus; Memory Disorders; Mutation; Neurons; Presenilin-1; Rats; Rats, Inbred F344; Rats, Transgenic; Receptor, Muscarinic M1; Recognition, Psychology

2018

Disease-Modifying Effects of M

ACS chemical neuroscience, 2017, 06-21, Volume: 8, Issue:6

Alzheimer's disease (AD) is the leading cause of dementia worldwide, and currently no disease-modifying therapy is available to slow or prevent AD, underscoring the urgent need for neuroprotective therapies. Selective M

Topics: Alzheimer Disease; Animals; Benzamides; Biphenyl Compounds; Brain; Maze Learning; Mice; Mice, Transgenic; Neuroprotective Agents; Receptor, Muscarinic M1

2017